Dextera Surgical Inc. is on the Cruelty Free Investing list for exploiting animals because the company uses animals for demonstration of their surgical instruments.
The company featured Microcutter 5/80 in a preclinical study of laparoscopic nephrectomy procedures.
“Leading surgeon Juan-Carlos Verdeja, M.D., presented a poster highlighting the MicroCutter Stapler as a procedure enabling technology in laparoscopic nephrectomy for kidney removal in an animal model. ” Read the full article.
Dextera Surgical, Inc. designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Its technology portfolio is minimizes operating time and enable minimally-invasive and robot-assisted surgeries. The company manufactures and markets automated anastomosis systems, the C-Port Distal Anastomosis systems and PAS-Port Proximal Anastomosis system for coronary artery bypass graft surgery. Dextera Surgical was founded by Bernard A. Hausen and Stephen A. Yencho on October 15, 1997 and is headquartered in Redwood City, CA. [Source: MarketWatch]
Company Website: https://www.dexterasurgical.com